Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 2Rehabilitation 1Pancreatic Diseases 1Pain, Postoperative 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Anaplasia 1Agnosia 1

Interventions

Cisplatin 38Carboplatin 28Gemcitabine 23Docetaxel 20Radiotherapy 18Etoposide 15Paclitaxel 13Erlotinib Hydrochloride 13Vinorelbine 11Drug Therapy 11pembrolizumab 9aumolertinib 9apatinib 9Pemetrexed 9Gefitinib 9osimertinib 7endostar protein 7Thoracic Surgery, Video-Assisted 7Blood Specimen Collection 7camrelizumab 6anlotinib 6Vinblastine 6Surgical Procedures, Operative 6sintilimab 5Radiosurgery 5Fluorodeoxyglucose F18 5Cyclophosphamide 5Bevacizumab 5durvalumab 4Mitomycin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lung Neoplasms × Rehabilitation × Clear all
NCT05332171 2022-04-18

Examination Of Exercise Adherence İn Lung Cancer Patients Given Calisthenic Exercise

Hasan Kalyoncu University

Phase NA Unknown
30 enrolled
Thoracic

Lung Neoplasms

NCT02439073 2016-06-24

PROLUCA

Rigshospitalet, Denmark

Phase NA Unknown
235 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡